Elagolix-d6 Sodium
| Product Name | Elagolix-d6 Sodium |
|---|---|
| Alternate Names | Elagolix Stable Isotopes, Stable Isotopes of Elagolix |
| CAT No. | CS-T-94147 |
| CAS No. | 832720-36-2 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 659.61 g/mol |
| Mol. For. | C₃₂H₂₃D₆F₅N₃NaO₅ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Elagolix |
| Canonical Smiles | CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+] |
| InchIKey | DQYGXRQUFSRDCH-UQIIZPHYSA-M |
| Inchl | InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1 |
| IUPAC | sodium;4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Elagolix-d6 Sodium is a deuterated form of Elagolix Sodium, a drug used for the treatment of endometriosis and uterine fibroids. It is an orally active, non-peptide, small molecule antagonist of gonadotropin-releasing hormone (GnRH) receptors. The deuterated form of Elagolix Sodium, Elagolix-d6 Sodium, contains six deuterium atoms and allows for more precise analysis of the drug in biological systems.
The chemical formula of Elagolix-d6 Sodium is C29H30D6N7O3Na, and its molecular weight is 570.68 g/mol. It is a white to off-white powder that is freely soluble in water and ethanol.
Elagolix-d6 Sodium works by suppressing the production of estrogen and progesterone, which are hormones responsible for the growth and maintenance of uterine fibroids and endometrial tissue. This leads to a reduction in the size of uterine fibroids and a decrease in pain associated with endometriosis.
The recommended dose of Elagolix-d6 Sodium is 200 mg twice daily, taken with or without food. It has a half-life of approximately 3-4 hours and is metabolized primarily in the liver.
In conclusion, Elagolix-d6 Sodium is a deuterated form of Elagolix Sodium used for the treatment of endometriosis and uterine fibroids. It works by suppressing the production of estrogen and progesterone, and is taken orally at a recommended dose of 200 mg twice daily.
Get an Instant Quote
Related Compounds
Elagolix-D9 Sodium Salt | Elagolix 13CD3 | Elagolix D9 | Elagolix D12 |